{
    "uniprot_canonical_ac": "A0A0R4IWI1-1",
    "uniprot_id": [
        {
            "id": "COE1A_DANRE",
            "url": "https://www.uniprot.org/uniprot/COE1A_DANRE",
            "type": "external"
        }
    ],
    "mass": 64371.0,
    "length": 591,
    "protein_name": "Transcription factor COE1-A",
    "gene_name": "ebf1a; ebf3a",
    "organism": "Zebrafish",
    "refseq_name": "transcription factor COE1-A isoform 1",
    "refseq_ac": [
        {
            "id": "NP_001410899",
            "url": "https://www.ncbi.nlm.nih.gov/protein/NP_001410899",
            "type": "external"
        }
    ],
    "gene_names_uniprotkb": "ebf1a; ebf3a; ebf3; sb:eu427; si:ch73-38f1.1; zgc:158829",
    "gene_names_refseq": "ebf1a; sb:eu427; si:ch73-38f1.1",
    "protein_names_uniprotkb": "Transcription factor COE1-A; Early B cell factor 1-A",
    "protein_names_refseq": "early B cell factor 1-A; transcription factor COE1; transcription factor COE1-A; early B cell factor 1a; transcription factor COE1-A isoform 1",
    "tax_id": 7955,
    "disease": "hypotonia, ataxia, and delayed development syndrome (Disease Ontology:DOID:0081176); lipodystrophy (Disease Ontology:DOID:811)",
    "pathway": " (dre:567751)",
    "pathway_count": 1,
    "publication_count": 14,
    "publication_id_list": "19449054;21061380;23594743;24034702;26095893;26982811;27189481;27615194;30045885;30681411;31908317;34667153;36414621;38017520",
    "function": "##Evidence-Data-START## RNAseq introns :: single sample supports all introns SAMEA3505389, SAMEA4476738 [ECO:0000348] ##Evidence-Data-END## VALIDATED REFSEQ: This record has undergone validation or preliminary review. The reference sequence was derived from CU019638.6, CU012046.8 and AL929292.8. On Aug 23, 2023 this sequence version replaced XP_009289484.1., [RefSeq]; Transcriptional activator., [UniProtKB, UniProtKB]",
    "predicted_glycosites": 1,
    "predicted_n_glycosites": 0,
    "predicted_o_glycosites": 1,
    "mined_glycosites": 0,
    "mined_n_glycosites": 0,
    "mined_o_glycosites": 0,
    "reported_n_glycosites": 0,
    "reported_o_glycosites": 0,
    "reported_n_glycosites_with_glycan": 0,
    "reported_o_glycosites_with_glycan": 0,
    "total_reported_n_glycosites": 0,
    "total_reported_o_glycosites": 0,
    "total_n_glycosites": 0,
    "total_o_glycosites": 1,
    "reported_fully_resolved_glycans": 0,
    "reported_phosphosites": 0,
    "reported_mutagensis": 0,
    "reported_glycation": 0,
    "reported_snv": 0,
    "reported_interactions": 0,
    "missing_score": 10000,
    "biomarker_type": "",
    "glycan_count": 0,
    "disease_count": 2,
    "glyco_site_count": 1,
    "binding_glycan_count": 0,
    "secondary_ac_list": "",
    "ec_number_list": [],
    "go_molecular_function": "GO:0003677 DNA binding;GO:0003700 DNA-binding transcription factor activity;GO:0008270 zinc ion binding;GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding;GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific",
    "go_cellular_component": "GO:0005634 nucleus",
    "go_biological_process": "GO:0007399 nervous system development;GO:0006357 regulation of transcription by RNA polymerase II",
    "synthesized_glycan_count": 0,
    "record_id": "A0A0R4IWI1-1",
    "record_type": "protein",
    "filter_code": "0000000.0000111.100000.0000000000000001.00010.001"
}